These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3787614)
1. Antibody dependent cellular cytotoxicity mediated by HLA-class II specific monoclonal antibodies. Koning F; Kardol M; Bruning H Tissue Antigens; 1986 Sep; 28(3):170-5. PubMed ID: 3787614 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells. Howard DR; Eaves AC; Takei F Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652 [TBL] [Abstract][Full Text] [Related]
3. Production and characterization of chimeric anti-HLA monoclonal antibodies targeting public epitopes as tools for standardizations of the anti-HLA antibody detection. Congy-Jolivet N; Drocourt D; Portet S; Tiraby G; Blancher A J Immunol Methods; 2013 Apr; 390(1-2):41-51. PubMed ID: 23352853 [TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors. Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). I. Blocking of bulk non-DR and non-DQ-directed cytotoxic T cells by MoAb against DR, DQ, and DP. Strassmann G; Ress S; Anichini A; Bach FH Hum Immunol; 1985 Jun; 13(2):125-37. PubMed ID: 3874193 [TBL] [Abstract][Full Text] [Related]
6. Role of HLA class I and class II antigens in activation and differentiation of B cells. Giudizi MG; Biagiotti R; Almerigogna F; Alessi A; Tiri A; Del Prete GF; Ferrone S; Romagnani S Cell Immunol; 1987 Aug; 108(1):97-108. PubMed ID: 3111726 [TBL] [Abstract][Full Text] [Related]
7. Functional roles of human class II antigens in T cell proliferative response. Comparison of the DR and DQ molecules using mouse monoclonal antibodies. Chen RF; Maeda H J Immunogenet; 1986; 13(5-6):401-13. PubMed ID: 3497988 [TBL] [Abstract][Full Text] [Related]
8. Xenogeneic recognition of soluble and cell surface HLA class II antigens by proliferative murine T cells. Viguier M; Lotteau V; Charron D; Debré P Eur J Immunol; 1987 Nov; 17(11):1540-6. PubMed ID: 2960540 [TBL] [Abstract][Full Text] [Related]
9. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity. Aparicio P; Jaraquemada D; López de Castro JA J Exp Med; 1987 Feb; 165(2):428-43. PubMed ID: 3102669 [TBL] [Abstract][Full Text] [Related]
10. Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures. Gorga JC; Knudsen PJ; Foran JA; Strominger JL; Burakoff SJ Cell Immunol; 1986 Nov; 103(1):160-73. PubMed ID: 3492282 [TBL] [Abstract][Full Text] [Related]
11. HLA class II antibodies in the treatment of hematologic malignancies. Dechant M; Bruenke J; Valerius T Semin Oncol; 2003 Aug; 30(4):465-75. PubMed ID: 12939715 [TBL] [Abstract][Full Text] [Related]
12. Serological biochemical and functional characterisation of three different HLA-DR monoclonal antibodies derived from C57BL6 mice. Sachs JA; Fernandez N; Kurpisz M; Okoye R; Ogilvie J; Awad J; Labeta M; Festenstein H Tissue Antigens; 1986 Oct; 28(4):199-207. PubMed ID: 2949394 [TBL] [Abstract][Full Text] [Related]
13. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues. Temponi M; Kekish U; Hamby CV; Nielsen H; Marboe CC; Ferrone S J Immunol Methods; 1993 May; 161(2):239-56. PubMed ID: 8505553 [TBL] [Abstract][Full Text] [Related]
14. The role of MHC class II antigenic determinants in the function of human antigen binding T8+ cells, monocytes and helper and suppressor factors. Lehner T; Jones T Clin Exp Immunol; 1984 Jun; 56(3):683-93. PubMed ID: 6204796 [TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal antibodies directed against HLA class II molecules. Cabrera T; Ruiz-Cabello F; Lopez MA; de la Higuera B; Sanchez M; Garrido F Hybridoma; 1986; 5(3):191-7. PubMed ID: 3770773 [TBL] [Abstract][Full Text] [Related]
16. Detection of antibodies specific for HLA-A,B,C,DR,DQ and DP by the erythrocyte antibody rosette inhibition (EAI) and immune phagocytosis inhibition (IPI) tests. Faust A; Neppert J J Immunol Methods; 1987 Aug; 102(1):71-5. PubMed ID: 3476673 [TBL] [Abstract][Full Text] [Related]
17. Anti-class II antibodies in AIDS patients and AIDS-risk groups. de la Barrera S; Fainboim L; Lugo S; Picchio GR; Muchinik GR; de Bracco MM Immunology; 1987 Dec; 62(4):599-604. PubMed ID: 3501399 [TBL] [Abstract][Full Text] [Related]
18. A supertypic HLA class II determinant shared by DR1 and DRw9, and crossreactive with DR2, defined by human monoclonal antibody. Kosinski S; Yang SY; Pistillo MP; Hämmerling U Hum Immunol; 1988 Mar; 21(3):221-31. PubMed ID: 2453492 [TBL] [Abstract][Full Text] [Related]
19. [Monoclonal antibodies against determinants on human MHC class II antigens]. Eichler W; Seifert M; Fiebig H Allerg Immunol (Leipz); 1990; 36(4):309-20. PubMed ID: 1711285 [TBL] [Abstract][Full Text] [Related]
20. HLA-DR expression by adrenocortical cells of the zona reticularis: structural and allotypic characterization. Khoury EL; Berline JW Tissue Antigens; 1988 Apr; 31(4):191-203. PubMed ID: 3043760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]